학술논문

Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2010, 28 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755